Heartbeam Inc (BEAT NASDAQ) stock market data APIs
$1.3001
0.06(4.6%)
as of February 5, 2026
Try our APIs with
free plan!
Heartbeam Inc Financial Data Overview
Price chart is built with
Anychart
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.
Prev. Close
1.3001
Open
1.3644
High
1.3834
Low
1.2993
52 wk Range
0.54-4
Market Cap
44 432 K
Shares Outstanding
34 444 K
EPS
-0.15
Beta
-0.806
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Heartbeam Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Heartbeam Inc data using free add-ons & libraries
Get Heartbeam Inc Fundamental Data
Heartbeam Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -19 880 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-13
- EPS/Forecast: -0.08
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Heartbeam Inc News
New
BEAT Secures FDA Nod for First Cable-Free At-Home 12-Lead ECG System
HeartBeam BEAT recently secured FDA 510(k) clearance for its first-of-its-kind, cable-free synthesized 12-lead ECG technology, marking a major inflection point in the company’s mission to modernize ...
FDA Clears First-Ever, Cable-Free Synthesized 12-Lead ECG For At-Home Arrhythmia Care; BEAT Surges
(RTTNews) - HeartBeam, Inc. (BEAT) announced that the U.S. FDA has granted 510(k) clearance for its proprietary cable-free synthesized 12-lead Electrocardiogram (ECG) system, making it the first FDA-c...
BC-Most Active Stocks
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Pasithea Therapeutics Corp. 98,...
HeartBeam Outlines Regulatory Path Following FDA NSE Decision On 12-Lead ECG Synthesis Software
(RTTNews) - HeartBeam Inc. (BEAT), on Wednesday, announced its regulatory strategy after receiving a Not Substantially Equivalent (NSE) decision from the U.S. Food and Drug Administration (FDA) on its...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
